These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37994420)
21. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Lee HY; Kim DK; Park YH; Cha WW; Kim GJ; Lee SH Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):143-149. PubMed ID: 27544193 [TBL] [Abstract][Full Text] [Related]
22. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460 [TBL] [Abstract][Full Text] [Related]
23. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial. Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028 [TBL] [Abstract][Full Text] [Related]
24. [Intratympanic methylprednisolone perfusion remedy refractory sudden sensorineural hearing loss]. Xie LS; Zhou QQ; Li Q; She WD Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):496-499. PubMed ID: 29871296 [No Abstract] [Full Text] [Related]
25. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534 [TBL] [Abstract][Full Text] [Related]
26. [Multi-center clinical study on the treatment of the low-middle frequency sudden hearing loss]. Zheng YQ; Ou YK; Xu YD; Zhang XY; Sun JJ; Liu Y; Lin YS; Diao MF; Chen DL; Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 48(5):362-7. PubMed ID: 24016558 [TBL] [Abstract][Full Text] [Related]
27. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss]. Sun RX; Zhao Y; Liu J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066 [No Abstract] [Full Text] [Related]
28. Short-term effects of intravenous batroxobin in treatment of sudden sensorineural hearing loss: a propensity score-matched study. Jiang M; Huang H; Mei L; He C; Cai X; Jiang L; Wu H; Wang X; Wu X Front Neurol; 2023; 14():1102297. PubMed ID: 37139065 [TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and prognosis of sudden sensorineural hearing loss with rheumatoid arthritis]. Wang G; Deng G; Liang J; Zhao Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jan; 35(1):9-13. PubMed ID: 33540963 [No Abstract] [Full Text] [Related]
30. Comparison of Batroxobin Versus the Combination of Batroxobin and Intratympanic Dexamethasone Injection in the Treatment of Sudden Sensorineural Hearing Loss. Jia Q; Zhu J; Wu D; Chen T; Hong C Ear Nose Throat J; 2024 Jan; ():1455613231222381. PubMed ID: 38282309 [No Abstract] [Full Text] [Related]
31. Prediction of hearing outcomes by auditory steady-state response in patients with sudden sensorineural hearing loss. Ahn JH; Choi JE Acta Otolaryngol; 2021 Mar; 141(3):261-266. PubMed ID: 33305656 [TBL] [Abstract][Full Text] [Related]
33. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929 [TBL] [Abstract][Full Text] [Related]
34. Analysis of Clinical Prognosis of Totally Deaf Idiopathic Sudden Sensorineural Hearing Loss in Different Ages. You D; You Q; Liu Y Altern Ther Health Med; 2023 Nov; 29(8):506-511. PubMed ID: 37652422 [TBL] [Abstract][Full Text] [Related]
35. Clinical Feature and Prognosis of Sudden Sensorineural Hearing Loss With Rheumatoid Arthritis. Li H; Zhang M; Wang M; Zhang S; Ma S; Wang X Otol Neurotol; 2021 Mar; 42(3):e267-e271. PubMed ID: 33021510 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial. Cho I; Lee HM; Choi SW; Kong SK; Lee IW; Goh EK; Oh SJ Audiol Neurootol; 2018; 23(4):199-207. PubMed ID: 30380530 [TBL] [Abstract][Full Text] [Related]
37. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Plontke S; Löwenheim H; Preyer S; Leins P; Dietz K; Koitschev A; Zimmermann R; Zenner HP Acta Otolaryngol; 2005 Aug; 125(8):830-9. PubMed ID: 16158529 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Various Corticosteroid Treatment Modalities for the Initial Treatment of Idiopathic Sudden Hearing Loss: A Prospective Randomized Controlled Trial. Tong B; Wang Q; Dai Q; Hellstrom S; Duan M Audiol Neurootol; 2021; 26(1):45-52. PubMed ID: 32668428 [TBL] [Abstract][Full Text] [Related]
39. Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss. Dai Y; Lu L; Hou J; Yang X; Li H; Yang Y; She W J Laryngol Otol; 2017 May; 131(5):404-410. PubMed ID: 28290919 [TBL] [Abstract][Full Text] [Related]
40. Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Shiraishi T; Kubo T; Matsunaga T Acta Otolaryngol; 1991; 111(5):867-71. PubMed ID: 1759572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]